date:Jun 01, 2012
significant reductions in homocysteine levels, and a 12% reduction in the risk of stroke, compared with placebo, but no differences were observed for other cardiovascular outcomes.
The discrepancies between the RCTs of B vitamins supplementation for the prevention of CVD may have various explanations,said the researchers.
First, it is possible that populations without folate deficiency may not benefit from folic acid supplementation
Second, RCTs may not avoid residual confounding. Different p